Global Ertapenem Supply, Demand and Key Producers, 2026-2032
The global Ertapenem market size is expected to reach $ 578 million by 2032, rising at a market growth of 4.6% CAGR during the forecast period (2026-2032).
Ertapenem is a long-acting, broad-spectrum carbapenem antibiotic, primarily supplied in the form of sterile powder for injection or injectable formulations, and is widely used for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and selected community-acquired infections. While maintaining strong activity against Gram-negative and anaerobic bacteria, it features a relatively low dosing frequency, making it well suited for standardized in-hospital medication management. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam intermediates, side-chain synthesis materials, excipients for sterile injectables such as fillers and stabilizers, aseptic consumables, and formulation equipment, all of which require stringent process control and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, and regional medical centers, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global production capacity of ertapenem in 2025 is estimated at approximately 160,000 vials, with actual sales volume of around 12.69 million vials and an average global ex-factory price of about USD 32.6 per vial. Influenced by technical barriers in sterile manufacturing, strict quality system requirements, and pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 45%?60%, reflecting a market characterized by scaled production, relatively stable pricing, and resilient profitability.
From a market perspective, the hospital anti-infective segment in which ertapenem is positioned is relatively mature and highly regulated. In most regions, the market has transitioned from original-brand dominance to a multi-supplier structure, with competition centered more on quality systems, supply reliability, and hospital access capabilities rather than purely on pricing. Given its well-defined clinical role, ertapenem is typically classified under restricted or closely managed antibiotic categories, resulting in relatively stable demand patterns closely linked to hospital treatment protocols and infection profiles.
In terms of demand drivers, the ongoing need to manage complicated infections and antimicrobial resistance continues to underpin ertapenem usage. Aging patient populations, increasing use of invasive procedures, and a growing number of immunocompromised patients support sustained hospital demand for antibiotics with predictable efficacy and convenient administration. At the same time, antimicrobial stewardship policies emphasize rational and targeted use, reinforcing ertapenem's role in specific indications rather than eliminating its clinical relevance.
Looking ahead, the market is expected to evolve through structural optimization rather than broad-based expansion. Hospitals are placing greater emphasis on medication safety, batch consistency, and uninterrupted supply, which favors manufacturers with robust sterile production capabilities and established quality compliance. Meanwhile, the introduction of newer antimicrobial agents and combination therapies may limit ertapenem's use in certain settings, but its suitability for infections with lower non-fermenter risk and simplified dosing requirements ensures continued relevance in defined clinical scenarios.
Against this backdrop, both growth drivers and constraints shape the market outlook. Stricter antibiotic control policies can curb inappropriate utilization, while the high regulatory and technical thresholds of sterile manufacturing increase operational complexity and cost sensitivity. Fluctuations in upstream materials and compliance expenditures may further affect profitability. For manufacturers, long-term competitiveness in the ertapenem market will depend on maintaining regulatory compliance, cost control, and reliable supply within an increasingly disciplined hospital prescribing environment.
This report studies the global Ertapenem production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ertapenem and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ertapenem that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ertapenem total production and demand, 2021-2032, (K Units)
Global Ertapenem total production value, 2021-2032, (USD Million)
Global Ertapenem production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ertapenem consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ertapenem domestic production, consumption, key domestic manufacturers and share
Global Ertapenem production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ertapenem production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ertapenem production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ertapenem market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Aurobindo Pharma, Endo International, CSPC Pharmaceutical Group, Apotex, Fresenius, Dr Reddy's Laboratories, Chongqing Shenghuaxi Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ertapenem market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ertapenem Market, By Region:
1. How big is the global Ertapenem market?
2. What is the demand of the global Ertapenem market?
3. What is the year over year growth of the global Ertapenem market?
4. What is the production and production value of the global Ertapenem market?
5. Who are the key producers in the global Ertapenem market?
6. What are the growth factors driving the market demand?
Ertapenem is a long-acting, broad-spectrum carbapenem antibiotic, primarily supplied in the form of sterile powder for injection or injectable formulations, and is widely used for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and selected community-acquired infections. While maintaining strong activity against Gram-negative and anaerobic bacteria, it features a relatively low dosing frequency, making it well suited for standardized in-hospital medication management. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam intermediates, side-chain synthesis materials, excipients for sterile injectables such as fillers and stabilizers, aseptic consumables, and formulation equipment, all of which require stringent process control and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, and regional medical centers, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global production capacity of ertapenem in 2025 is estimated at approximately 160,000 vials, with actual sales volume of around 12.69 million vials and an average global ex-factory price of about USD 32.6 per vial. Influenced by technical barriers in sterile manufacturing, strict quality system requirements, and pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 45%?60%, reflecting a market characterized by scaled production, relatively stable pricing, and resilient profitability.
From a market perspective, the hospital anti-infective segment in which ertapenem is positioned is relatively mature and highly regulated. In most regions, the market has transitioned from original-brand dominance to a multi-supplier structure, with competition centered more on quality systems, supply reliability, and hospital access capabilities rather than purely on pricing. Given its well-defined clinical role, ertapenem is typically classified under restricted or closely managed antibiotic categories, resulting in relatively stable demand patterns closely linked to hospital treatment protocols and infection profiles.
In terms of demand drivers, the ongoing need to manage complicated infections and antimicrobial resistance continues to underpin ertapenem usage. Aging patient populations, increasing use of invasive procedures, and a growing number of immunocompromised patients support sustained hospital demand for antibiotics with predictable efficacy and convenient administration. At the same time, antimicrobial stewardship policies emphasize rational and targeted use, reinforcing ertapenem's role in specific indications rather than eliminating its clinical relevance.
Looking ahead, the market is expected to evolve through structural optimization rather than broad-based expansion. Hospitals are placing greater emphasis on medication safety, batch consistency, and uninterrupted supply, which favors manufacturers with robust sterile production capabilities and established quality compliance. Meanwhile, the introduction of newer antimicrobial agents and combination therapies may limit ertapenem's use in certain settings, but its suitability for infections with lower non-fermenter risk and simplified dosing requirements ensures continued relevance in defined clinical scenarios.
Against this backdrop, both growth drivers and constraints shape the market outlook. Stricter antibiotic control policies can curb inappropriate utilization, while the high regulatory and technical thresholds of sterile manufacturing increase operational complexity and cost sensitivity. Fluctuations in upstream materials and compliance expenditures may further affect profitability. For manufacturers, long-term competitiveness in the ertapenem market will depend on maintaining regulatory compliance, cost control, and reliable supply within an increasingly disciplined hospital prescribing environment.
This report studies the global Ertapenem production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ertapenem and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ertapenem that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ertapenem total production and demand, 2021-2032, (K Units)
Global Ertapenem total production value, 2021-2032, (USD Million)
Global Ertapenem production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ertapenem consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ertapenem domestic production, consumption, key domestic manufacturers and share
Global Ertapenem production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ertapenem production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ertapenem production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ertapenem market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Aurobindo Pharma, Endo International, CSPC Pharmaceutical Group, Apotex, Fresenius, Dr Reddy's Laboratories, Chongqing Shenghuaxi Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ertapenem market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ertapenem Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sterile Powder for Injection
- Ready-to-use or Premixed Injection
- Others
- Complicated Intra-abdominal Infections
- Complicated Urinary Tract Infections
- Others
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Others
- Merck
- Aurobindo Pharma
- Endo International
- CSPC Pharmaceutical Group
- Apotex
- Fresenius
- Dr Reddy's Laboratories
- Chongqing Shenghuaxi Pharm
1. How big is the global Ertapenem market?
2. What is the demand of the global Ertapenem market?
3. What is the year over year growth of the global Ertapenem market?
4. What is the production and production value of the global Ertapenem market?
5. Who are the key producers in the global Ertapenem market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Ertapenem Introduction
1.2 World Ertapenem Supply & Forecast
1.2.1 World Ertapenem Production Value (2021 & 2025 & 2032)
1.2.2 World Ertapenem Production (2021-2032)
1.2.3 World Ertapenem Pricing Trends (2021-2032)
1.3 World Ertapenem Production by Region (Based on Production Site)
1.3.1 World Ertapenem Production Value by Region (2021-2032)
1.3.2 World Ertapenem Production by Region (2021-2032)
1.3.3 World Ertapenem Average Price by Region (2021-2032)
1.3.4 North America Ertapenem Production (2021-2032)
1.3.5 Europe Ertapenem Production (2021-2032)
1.3.6 China Ertapenem Production (2021-2032)
1.3.7 Japan Ertapenem Production (2021-2032)
1.3.8 India Ertapenem Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ertapenem Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ertapenem Major Market Trends
2 DEMAND SUMMARY
2.1 World Ertapenem Demand (2021-2032)
2.2 World Ertapenem Consumption by Region
2.2.1 World Ertapenem Consumption by Region (2021-2026)
2.2.2 World Ertapenem Consumption Forecast by Region (2027-2032)
2.3 United States Ertapenem Consumption (2021-2032)
2.4 China Ertapenem Consumption (2021-2032)
2.5 Europe Ertapenem Consumption (2021-2032)
2.6 Japan Ertapenem Consumption (2021-2032)
2.7 South Korea Ertapenem Consumption (2021-2032)
2.8 ASEAN Ertapenem Consumption (2021-2032)
2.9 India Ertapenem Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ertapenem Production Value by Manufacturer (2021-2026)
3.2 World Ertapenem Production by Manufacturer (2021-2026)
3.3 World Ertapenem Average Price by Manufacturer (2021-2026)
3.4 Ertapenem Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ertapenem Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ertapenem in 2025
3.5.3 Global Concentration Ratios (CR8) for Ertapenem in 2025
3.6 Ertapenem Market: Overall Company Footprint Analysis
3.6.1 Ertapenem Market: Region Footprint
3.6.2 Ertapenem Market: Company Product Type Footprint
3.6.3 Ertapenem Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ertapenem Production Value Comparison
4.1.1 United States VS China: Ertapenem Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ertapenem Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ertapenem Production Comparison
4.2.1 United States VS China: Ertapenem Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ertapenem Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ertapenem Consumption Comparison
4.3.1 United States VS China: Ertapenem Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ertapenem Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ertapenem Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ertapenem Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ertapenem Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ertapenem Production (2021-2026)
4.5 China Based Ertapenem Manufacturers and Market Share
4.5.1 China Based Ertapenem Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ertapenem Production Value (2021-2026)
4.5.3 China Based Manufacturers Ertapenem Production (2021-2026)
4.6 Rest of World Based Ertapenem Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ertapenem Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ertapenem Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ertapenem Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Ertapenem Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Sterile Powder for Injection
5.2.2 Ready-to-use or Premixed Injection
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Ertapenem Production by Type (2021-2032)
5.3.2 World Ertapenem Production Value by Type (2021-2032)
5.3.3 World Ertapenem Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Ertapenem Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Complicated Intra-abdominal Infections
6.2.2 Complicated Urinary Tract Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Ertapenem Production by Clinical Indication (2021-2032)
6.3.2 World Ertapenem Production Value by Clinical Indication (2021-2032)
6.3.3 World Ertapenem Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY SALE CHANNELS
7.1 World Ertapenem Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sale Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sale Channels
7.3.1 World Ertapenem Production by Sale Channels (2021-2032)
7.3.2 World Ertapenem Production Value by Sale Channels (2021-2032)
7.3.3 World Ertapenem Average Price by Sale Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Ertapenem Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Ertapenem Production by Application (2021-2032)
8.3.2 World Ertapenem Production Value by Application (2021-2032)
8.3.3 World Ertapenem Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck
9.1.1 Merck Details
9.1.2 Merck Major Business
9.1.3 Merck Ertapenem Product and Services
9.1.4 Merck Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Recent Developments/Updates
9.1.6 Merck Competitive Strengths & Weaknesses
9.2 Aurobindo Pharma
9.2.1 Aurobindo Pharma Details
9.2.2 Aurobindo Pharma Major Business
9.2.3 Aurobindo Pharma Ertapenem Product and Services
9.2.4 Aurobindo Pharma Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Aurobindo Pharma Recent Developments/Updates
9.2.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.3 Endo International
9.3.1 Endo International Details
9.3.2 Endo International Major Business
9.3.3 Endo International Ertapenem Product and Services
9.3.4 Endo International Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Endo International Recent Developments/Updates
9.3.6 Endo International Competitive Strengths & Weaknesses
9.4 CSPC Pharmaceutical Group
9.4.1 CSPC Pharmaceutical Group Details
9.4.2 CSPC Pharmaceutical Group Major Business
9.4.3 CSPC Pharmaceutical Group Ertapenem Product and Services
9.4.4 CSPC Pharmaceutical Group Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.4.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.5 Apotex
9.5.1 Apotex Details
9.5.2 Apotex Major Business
9.5.3 Apotex Ertapenem Product and Services
9.5.4 Apotex Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Apotex Recent Developments/Updates
9.5.6 Apotex Competitive Strengths & Weaknesses
9.6 Fresenius
9.6.1 Fresenius Details
9.6.2 Fresenius Major Business
9.6.3 Fresenius Ertapenem Product and Services
9.6.4 Fresenius Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Fresenius Recent Developments/Updates
9.6.6 Fresenius Competitive Strengths & Weaknesses
9.7 Dr Reddy's Laboratories
9.7.1 Dr Reddy's Laboratories Details
9.7.2 Dr Reddy's Laboratories Major Business
9.7.3 Dr Reddy's Laboratories Ertapenem Product and Services
9.7.4 Dr Reddy's Laboratories Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dr Reddy's Laboratories Recent Developments/Updates
9.7.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.8 Chongqing Shenghuaxi Pharm
9.8.1 Chongqing Shenghuaxi Pharm Details
9.8.2 Chongqing Shenghuaxi Pharm Major Business
9.8.3 Chongqing Shenghuaxi Pharm Ertapenem Product and Services
9.8.4 Chongqing Shenghuaxi Pharm Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Chongqing Shenghuaxi Pharm Recent Developments/Updates
9.8.6 Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Ertapenem Industry Chain
10.2 Ertapenem Upstream Analysis
10.2.1 Ertapenem Core Raw Materials
10.2.2 Main Manufacturers of Ertapenem Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Ertapenem Production Mode
10.6 Ertapenem Procurement Model
10.7 Ertapenem Industry Sales Model and Sales Channels
10.7.1 Ertapenem Sales Model
10.7.2 Ertapenem Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Ertapenem Introduction
1.2 World Ertapenem Supply & Forecast
1.2.1 World Ertapenem Production Value (2021 & 2025 & 2032)
1.2.2 World Ertapenem Production (2021-2032)
1.2.3 World Ertapenem Pricing Trends (2021-2032)
1.3 World Ertapenem Production by Region (Based on Production Site)
1.3.1 World Ertapenem Production Value by Region (2021-2032)
1.3.2 World Ertapenem Production by Region (2021-2032)
1.3.3 World Ertapenem Average Price by Region (2021-2032)
1.3.4 North America Ertapenem Production (2021-2032)
1.3.5 Europe Ertapenem Production (2021-2032)
1.3.6 China Ertapenem Production (2021-2032)
1.3.7 Japan Ertapenem Production (2021-2032)
1.3.8 India Ertapenem Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ertapenem Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ertapenem Major Market Trends
2 DEMAND SUMMARY
2.1 World Ertapenem Demand (2021-2032)
2.2 World Ertapenem Consumption by Region
2.2.1 World Ertapenem Consumption by Region (2021-2026)
2.2.2 World Ertapenem Consumption Forecast by Region (2027-2032)
2.3 United States Ertapenem Consumption (2021-2032)
2.4 China Ertapenem Consumption (2021-2032)
2.5 Europe Ertapenem Consumption (2021-2032)
2.6 Japan Ertapenem Consumption (2021-2032)
2.7 South Korea Ertapenem Consumption (2021-2032)
2.8 ASEAN Ertapenem Consumption (2021-2032)
2.9 India Ertapenem Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ertapenem Production Value by Manufacturer (2021-2026)
3.2 World Ertapenem Production by Manufacturer (2021-2026)
3.3 World Ertapenem Average Price by Manufacturer (2021-2026)
3.4 Ertapenem Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ertapenem Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ertapenem in 2025
3.5.3 Global Concentration Ratios (CR8) for Ertapenem in 2025
3.6 Ertapenem Market: Overall Company Footprint Analysis
3.6.1 Ertapenem Market: Region Footprint
3.6.2 Ertapenem Market: Company Product Type Footprint
3.6.3 Ertapenem Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ertapenem Production Value Comparison
4.1.1 United States VS China: Ertapenem Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ertapenem Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ertapenem Production Comparison
4.2.1 United States VS China: Ertapenem Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ertapenem Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ertapenem Consumption Comparison
4.3.1 United States VS China: Ertapenem Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ertapenem Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ertapenem Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ertapenem Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ertapenem Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ertapenem Production (2021-2026)
4.5 China Based Ertapenem Manufacturers and Market Share
4.5.1 China Based Ertapenem Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ertapenem Production Value (2021-2026)
4.5.3 China Based Manufacturers Ertapenem Production (2021-2026)
4.6 Rest of World Based Ertapenem Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ertapenem Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ertapenem Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ertapenem Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Ertapenem Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Sterile Powder for Injection
5.2.2 Ready-to-use or Premixed Injection
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Ertapenem Production by Type (2021-2032)
5.3.2 World Ertapenem Production Value by Type (2021-2032)
5.3.3 World Ertapenem Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Ertapenem Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Complicated Intra-abdominal Infections
6.2.2 Complicated Urinary Tract Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Ertapenem Production by Clinical Indication (2021-2032)
6.3.2 World Ertapenem Production Value by Clinical Indication (2021-2032)
6.3.3 World Ertapenem Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY SALE CHANNELS
7.1 World Ertapenem Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sale Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sale Channels
7.3.1 World Ertapenem Production by Sale Channels (2021-2032)
7.3.2 World Ertapenem Production Value by Sale Channels (2021-2032)
7.3.3 World Ertapenem Average Price by Sale Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Ertapenem Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Ertapenem Production by Application (2021-2032)
8.3.2 World Ertapenem Production Value by Application (2021-2032)
8.3.3 World Ertapenem Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck
9.1.1 Merck Details
9.1.2 Merck Major Business
9.1.3 Merck Ertapenem Product and Services
9.1.4 Merck Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Recent Developments/Updates
9.1.6 Merck Competitive Strengths & Weaknesses
9.2 Aurobindo Pharma
9.2.1 Aurobindo Pharma Details
9.2.2 Aurobindo Pharma Major Business
9.2.3 Aurobindo Pharma Ertapenem Product and Services
9.2.4 Aurobindo Pharma Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Aurobindo Pharma Recent Developments/Updates
9.2.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.3 Endo International
9.3.1 Endo International Details
9.3.2 Endo International Major Business
9.3.3 Endo International Ertapenem Product and Services
9.3.4 Endo International Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Endo International Recent Developments/Updates
9.3.6 Endo International Competitive Strengths & Weaknesses
9.4 CSPC Pharmaceutical Group
9.4.1 CSPC Pharmaceutical Group Details
9.4.2 CSPC Pharmaceutical Group Major Business
9.4.3 CSPC Pharmaceutical Group Ertapenem Product and Services
9.4.4 CSPC Pharmaceutical Group Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.4.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.5 Apotex
9.5.1 Apotex Details
9.5.2 Apotex Major Business
9.5.3 Apotex Ertapenem Product and Services
9.5.4 Apotex Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Apotex Recent Developments/Updates
9.5.6 Apotex Competitive Strengths & Weaknesses
9.6 Fresenius
9.6.1 Fresenius Details
9.6.2 Fresenius Major Business
9.6.3 Fresenius Ertapenem Product and Services
9.6.4 Fresenius Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Fresenius Recent Developments/Updates
9.6.6 Fresenius Competitive Strengths & Weaknesses
9.7 Dr Reddy's Laboratories
9.7.1 Dr Reddy's Laboratories Details
9.7.2 Dr Reddy's Laboratories Major Business
9.7.3 Dr Reddy's Laboratories Ertapenem Product and Services
9.7.4 Dr Reddy's Laboratories Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dr Reddy's Laboratories Recent Developments/Updates
9.7.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.8 Chongqing Shenghuaxi Pharm
9.8.1 Chongqing Shenghuaxi Pharm Details
9.8.2 Chongqing Shenghuaxi Pharm Major Business
9.8.3 Chongqing Shenghuaxi Pharm Ertapenem Product and Services
9.8.4 Chongqing Shenghuaxi Pharm Ertapenem Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Chongqing Shenghuaxi Pharm Recent Developments/Updates
9.8.6 Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Ertapenem Industry Chain
10.2 Ertapenem Upstream Analysis
10.2.1 Ertapenem Core Raw Materials
10.2.2 Main Manufacturers of Ertapenem Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Ertapenem Production Mode
10.6 Ertapenem Procurement Model
10.7 Ertapenem Industry Sales Model and Sales Channels
10.7.1 Ertapenem Sales Model
10.7.2 Ertapenem Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Ertapenem Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ertapenem Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ertapenem Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ertapenem Production Value Market Share by Region (2021-2026)
Table 5. World Ertapenem Production Value Market Share by Region (2027-2032)
Table 6. World Ertapenem Production by Region (2021-2026) & (K Units)
Table 7. World Ertapenem Production by Region (2027-2032) & (K Units)
Table 8. World Ertapenem Production Market Share by Region (2021-2026)
Table 9. World Ertapenem Production Market Share by Region (2027-2032)
Table 10. World Ertapenem Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ertapenem Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ertapenem Major Market Trends
Table 13. World Ertapenem Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ertapenem Consumption by Region (2021-2026) & (K Units)
Table 15. World Ertapenem Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ertapenem Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ertapenem Producers in 2025
Table 18. World Ertapenem Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ertapenem Producers in 2025
Table 20. World Ertapenem Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ertapenem Company Evaluation Quadrant
Table 22. World Ertapenem Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ertapenem Production Site of Key Manufacturer
Table 24. Ertapenem Market: Company Product Type Footprint
Table 25. Ertapenem Market: Company Product Application Footprint
Table 26. Ertapenem Competitive Factors
Table 27. Ertapenem New Entrant and Capacity Expansion Plans
Table 28. Ertapenem Mergers & Acquisitions Activity
Table 29. United States VS China Ertapenem Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ertapenem Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ertapenem Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ertapenem Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ertapenem Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 37. China Based Ertapenem Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ertapenem Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 42. Rest of World Based Ertapenem Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ertapenem Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 47. World Ertapenem Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Ertapenem Production by Type (2021-2026) & (K Units)
Table 49. World Ertapenem Production by Type (2027-2032) & (K Units)
Table 50. World Ertapenem Production Value by Type (2021-2026) & (USD Million)
Table 51. World Ertapenem Production Value by Type (2027-2032) & (USD Million)
Table 52. World Ertapenem Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Ertapenem Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Ertapenem Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Ertapenem Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Ertapenem Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Ertapenem Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Ertapenem Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Ertapenem Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Ertapenem Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Ertapenem Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Ertapenem Production by Sale Channels (2021-2026) & (K Units)
Table 63. World Ertapenem Production by Sale Channels (2027-2032) & (K Units)
Table 64. World Ertapenem Production Value by Sale Channels (2021-2026) & (USD Million)
Table 65. World Ertapenem Production Value by Sale Channels (2027-2032) & (USD Million)
Table 66. World Ertapenem Average Price by Sale Channels (2021-2026) & (US$/Unit)
Table 67. World Ertapenem Average Price by Sale Channels (2027-2032) & (US$/Unit)
Table 68. World Ertapenem Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Ertapenem Production by Application (2021-2026) & (K Units)
Table 70. World Ertapenem Production by Application (2027-2032) & (K Units)
Table 71. World Ertapenem Production Value by Application (2021-2026) & (USD Million)
Table 72. World Ertapenem Production Value by Application (2027-2032) & (USD Million)
Table 73. World Ertapenem Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Ertapenem Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Merck Basic Information, Manufacturing Base and Competitors
Table 76. Merck Major Business
Table 77. Merck Ertapenem Product and Services
Table 78. Merck Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Merck Recent Developments/Updates
Table 80. Merck Competitive Strengths & Weaknesses
Table 81. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Aurobindo Pharma Major Business
Table 83. Aurobindo Pharma Ertapenem Product and Services
Table 84. Aurobindo Pharma Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Aurobindo Pharma Recent Developments/Updates
Table 86. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 87. Endo International Basic Information, Manufacturing Base and Competitors
Table 88. Endo International Major Business
Table 89. Endo International Ertapenem Product and Services
Table 90. Endo International Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Endo International Recent Developments/Updates
Table 92. Endo International Competitive Strengths & Weaknesses
Table 93. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 94. CSPC Pharmaceutical Group Major Business
Table 95. CSPC Pharmaceutical Group Ertapenem Product and Services
Table 96. CSPC Pharmaceutical Group Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. CSPC Pharmaceutical Group Recent Developments/Updates
Table 98. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 99. Apotex Basic Information, Manufacturing Base and Competitors
Table 100. Apotex Major Business
Table 101. Apotex Ertapenem Product and Services
Table 102. Apotex Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Apotex Recent Developments/Updates
Table 104. Apotex Competitive Strengths & Weaknesses
Table 105. Fresenius Basic Information, Manufacturing Base and Competitors
Table 106. Fresenius Major Business
Table 107. Fresenius Ertapenem Product and Services
Table 108. Fresenius Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Fresenius Recent Developments/Updates
Table 110. Fresenius Competitive Strengths & Weaknesses
Table 111. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 112. Dr Reddy's Laboratories Major Business
Table 113. Dr Reddy's Laboratories Ertapenem Product and Services
Table 114. Dr Reddy's Laboratories Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dr Reddy's Laboratories Recent Developments/Updates
Table 116. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 117. Chongqing Shenghuaxi Pharm Basic Information, Manufacturing Base and Competitors
Table 118. Chongqing Shenghuaxi Pharm Major Business
Table 119. Chongqing Shenghuaxi Pharm Ertapenem Product and Services
Table 120. Chongqing Shenghuaxi Pharm Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Chongqing Shenghuaxi Pharm Recent Developments/Updates
Table 122. Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
Table 123. Global Key Players of Ertapenem Upstream (Raw Materials)
Table 124. Global Ertapenem Typical Customers
Table 125. Ertapenem Typical Distributors
Table 1. World Ertapenem Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ertapenem Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ertapenem Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ertapenem Production Value Market Share by Region (2021-2026)
Table 5. World Ertapenem Production Value Market Share by Region (2027-2032)
Table 6. World Ertapenem Production by Region (2021-2026) & (K Units)
Table 7. World Ertapenem Production by Region (2027-2032) & (K Units)
Table 8. World Ertapenem Production Market Share by Region (2021-2026)
Table 9. World Ertapenem Production Market Share by Region (2027-2032)
Table 10. World Ertapenem Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ertapenem Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ertapenem Major Market Trends
Table 13. World Ertapenem Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ertapenem Consumption by Region (2021-2026) & (K Units)
Table 15. World Ertapenem Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ertapenem Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ertapenem Producers in 2025
Table 18. World Ertapenem Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ertapenem Producers in 2025
Table 20. World Ertapenem Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ertapenem Company Evaluation Quadrant
Table 22. World Ertapenem Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ertapenem Production Site of Key Manufacturer
Table 24. Ertapenem Market: Company Product Type Footprint
Table 25. Ertapenem Market: Company Product Application Footprint
Table 26. Ertapenem Competitive Factors
Table 27. Ertapenem New Entrant and Capacity Expansion Plans
Table 28. Ertapenem Mergers & Acquisitions Activity
Table 29. United States VS China Ertapenem Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ertapenem Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ertapenem Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ertapenem Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ertapenem Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 37. China Based Ertapenem Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ertapenem Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 42. Rest of World Based Ertapenem Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ertapenem Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ertapenem Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ertapenem Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ertapenem Production Market Share (2021-2026)
Table 47. World Ertapenem Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Ertapenem Production by Type (2021-2026) & (K Units)
Table 49. World Ertapenem Production by Type (2027-2032) & (K Units)
Table 50. World Ertapenem Production Value by Type (2021-2026) & (USD Million)
Table 51. World Ertapenem Production Value by Type (2027-2032) & (USD Million)
Table 52. World Ertapenem Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Ertapenem Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Ertapenem Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Ertapenem Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Ertapenem Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Ertapenem Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Ertapenem Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Ertapenem Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Ertapenem Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Ertapenem Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Ertapenem Production by Sale Channels (2021-2026) & (K Units)
Table 63. World Ertapenem Production by Sale Channels (2027-2032) & (K Units)
Table 64. World Ertapenem Production Value by Sale Channels (2021-2026) & (USD Million)
Table 65. World Ertapenem Production Value by Sale Channels (2027-2032) & (USD Million)
Table 66. World Ertapenem Average Price by Sale Channels (2021-2026) & (US$/Unit)
Table 67. World Ertapenem Average Price by Sale Channels (2027-2032) & (US$/Unit)
Table 68. World Ertapenem Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Ertapenem Production by Application (2021-2026) & (K Units)
Table 70. World Ertapenem Production by Application (2027-2032) & (K Units)
Table 71. World Ertapenem Production Value by Application (2021-2026) & (USD Million)
Table 72. World Ertapenem Production Value by Application (2027-2032) & (USD Million)
Table 73. World Ertapenem Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Ertapenem Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Merck Basic Information, Manufacturing Base and Competitors
Table 76. Merck Major Business
Table 77. Merck Ertapenem Product and Services
Table 78. Merck Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Merck Recent Developments/Updates
Table 80. Merck Competitive Strengths & Weaknesses
Table 81. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Aurobindo Pharma Major Business
Table 83. Aurobindo Pharma Ertapenem Product and Services
Table 84. Aurobindo Pharma Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Aurobindo Pharma Recent Developments/Updates
Table 86. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 87. Endo International Basic Information, Manufacturing Base and Competitors
Table 88. Endo International Major Business
Table 89. Endo International Ertapenem Product and Services
Table 90. Endo International Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Endo International Recent Developments/Updates
Table 92. Endo International Competitive Strengths & Weaknesses
Table 93. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 94. CSPC Pharmaceutical Group Major Business
Table 95. CSPC Pharmaceutical Group Ertapenem Product and Services
Table 96. CSPC Pharmaceutical Group Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. CSPC Pharmaceutical Group Recent Developments/Updates
Table 98. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 99. Apotex Basic Information, Manufacturing Base and Competitors
Table 100. Apotex Major Business
Table 101. Apotex Ertapenem Product and Services
Table 102. Apotex Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Apotex Recent Developments/Updates
Table 104. Apotex Competitive Strengths & Weaknesses
Table 105. Fresenius Basic Information, Manufacturing Base and Competitors
Table 106. Fresenius Major Business
Table 107. Fresenius Ertapenem Product and Services
Table 108. Fresenius Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Fresenius Recent Developments/Updates
Table 110. Fresenius Competitive Strengths & Weaknesses
Table 111. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 112. Dr Reddy's Laboratories Major Business
Table 113. Dr Reddy's Laboratories Ertapenem Product and Services
Table 114. Dr Reddy's Laboratories Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dr Reddy's Laboratories Recent Developments/Updates
Table 116. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 117. Chongqing Shenghuaxi Pharm Basic Information, Manufacturing Base and Competitors
Table 118. Chongqing Shenghuaxi Pharm Major Business
Table 119. Chongqing Shenghuaxi Pharm Ertapenem Product and Services
Table 120. Chongqing Shenghuaxi Pharm Ertapenem Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Chongqing Shenghuaxi Pharm Recent Developments/Updates
Table 122. Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
Table 123. Global Key Players of Ertapenem Upstream (Raw Materials)
Table 124. Global Ertapenem Typical Customers
Table 125. Ertapenem Typical Distributors
LIST OF FIGURES
Figure 1. Ertapenem Picture
Figure 2. World Ertapenem Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ertapenem Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ertapenem Production (2021-2032) & (K Units)
Figure 5. World Ertapenem Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ertapenem Production Value Market Share by Region (2021-2032)
Figure 7. World Ertapenem Production Market Share by Region (2021-2032)
Figure 8. North America Ertapenem Production (2021-2032) & (K Units)
Figure 9. Europe Ertapenem Production (2021-2032) & (K Units)
Figure 10. China Ertapenem Production (2021-2032) & (K Units)
Figure 11. Japan Ertapenem Production (2021-2032) & (K Units)
Figure 12. India Ertapenem Production (2021-2032) & (K Units)
Figure 13. Ertapenem Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Ertapenem Consumption (2021-2032) & (K Units)
Figure 16. World Ertapenem Consumption Market Share by Region (2021-2032)
Figure 17. United States Ertapenem Consumption (2021-2032) & (K Units)
Figure 18. China Ertapenem Consumption (2021-2032) & (K Units)
Figure 19. Europe Ertapenem Consumption (2021-2032) & (K Units)
Figure 20. Japan Ertapenem Consumption (2021-2032) & (K Units)
Figure 21. South Korea Ertapenem Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Ertapenem Consumption (2021-2032) & (K Units)
Figure 23. India Ertapenem Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Ertapenem by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Ertapenem Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Ertapenem Markets in 2025
Figure 27. United States VS China: Ertapenem Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ertapenem Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Ertapenem Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Ertapenem Production Market Share 2025
Figure 31. China Based Manufacturers Ertapenem Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Ertapenem Production Market Share 2025
Figure 33. World Ertapenem Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Ertapenem Production Value Market Share by Type in 2025
Figure 35. Sterile Powder for Injection
Figure 36. Ready-to-use or Premixed Injection
Figure 37. Others
Figure 38. World Ertapenem Production Market Share by Type (2021-2032)
Figure 39. World Ertapenem Production Value Market Share by Type (2021-2032)
Figure 40. World Ertapenem Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Ertapenem Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 42. World Ertapenem Production Value Market Share by Clinical Indication in 2025
Figure 43. Complicated Intra-abdominal Infections
Figure 44. Complicated Urinary Tract Infections
Figure 45. Others
Figure 46. World Ertapenem Production Market Share by Clinical Indication (2021-2032)
Figure 47. World Ertapenem Production Value Market Share by Clinical Indication (2021-2032)
Figure 48. World Ertapenem Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 49. World Ertapenem Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 50. World Ertapenem Production Value Market Share by Sale Channels in 2025
Figure 51. Online Sales
Figure 52. Offline Sales
Figure 53. World Ertapenem Production Market Share by Sale Channels (2021-2032)
Figure 54. World Ertapenem Production Value Market Share by Sale Channels (2021-2032)
Figure 55. World Ertapenem Average Price by Sale Channels (2021-2032) & (US$/Unit)
Figure 56. World Ertapenem Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Ertapenem Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Ertapenem Production Market Share by Application (2021-2032)
Figure 62. World Ertapenem Production Value Market Share by Application (2021-2032)
Figure 63. World Ertapenem Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Ertapenem Industry Chain
Figure 65. Ertapenem Procurement Model
Figure 66. Ertapenem Sales Model
Figure 67. Ertapenem Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Ertapenem Picture
Figure 2. World Ertapenem Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ertapenem Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ertapenem Production (2021-2032) & (K Units)
Figure 5. World Ertapenem Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ertapenem Production Value Market Share by Region (2021-2032)
Figure 7. World Ertapenem Production Market Share by Region (2021-2032)
Figure 8. North America Ertapenem Production (2021-2032) & (K Units)
Figure 9. Europe Ertapenem Production (2021-2032) & (K Units)
Figure 10. China Ertapenem Production (2021-2032) & (K Units)
Figure 11. Japan Ertapenem Production (2021-2032) & (K Units)
Figure 12. India Ertapenem Production (2021-2032) & (K Units)
Figure 13. Ertapenem Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Ertapenem Consumption (2021-2032) & (K Units)
Figure 16. World Ertapenem Consumption Market Share by Region (2021-2032)
Figure 17. United States Ertapenem Consumption (2021-2032) & (K Units)
Figure 18. China Ertapenem Consumption (2021-2032) & (K Units)
Figure 19. Europe Ertapenem Consumption (2021-2032) & (K Units)
Figure 20. Japan Ertapenem Consumption (2021-2032) & (K Units)
Figure 21. South Korea Ertapenem Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Ertapenem Consumption (2021-2032) & (K Units)
Figure 23. India Ertapenem Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Ertapenem by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Ertapenem Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Ertapenem Markets in 2025
Figure 27. United States VS China: Ertapenem Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ertapenem Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Ertapenem Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Ertapenem Production Market Share 2025
Figure 31. China Based Manufacturers Ertapenem Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Ertapenem Production Market Share 2025
Figure 33. World Ertapenem Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Ertapenem Production Value Market Share by Type in 2025
Figure 35. Sterile Powder for Injection
Figure 36. Ready-to-use or Premixed Injection
Figure 37. Others
Figure 38. World Ertapenem Production Market Share by Type (2021-2032)
Figure 39. World Ertapenem Production Value Market Share by Type (2021-2032)
Figure 40. World Ertapenem Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Ertapenem Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 42. World Ertapenem Production Value Market Share by Clinical Indication in 2025
Figure 43. Complicated Intra-abdominal Infections
Figure 44. Complicated Urinary Tract Infections
Figure 45. Others
Figure 46. World Ertapenem Production Market Share by Clinical Indication (2021-2032)
Figure 47. World Ertapenem Production Value Market Share by Clinical Indication (2021-2032)
Figure 48. World Ertapenem Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 49. World Ertapenem Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 50. World Ertapenem Production Value Market Share by Sale Channels in 2025
Figure 51. Online Sales
Figure 52. Offline Sales
Figure 53. World Ertapenem Production Market Share by Sale Channels (2021-2032)
Figure 54. World Ertapenem Production Value Market Share by Sale Channels (2021-2032)
Figure 55. World Ertapenem Average Price by Sale Channels (2021-2032) & (US$/Unit)
Figure 56. World Ertapenem Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Ertapenem Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Ertapenem Production Market Share by Application (2021-2032)
Figure 62. World Ertapenem Production Value Market Share by Application (2021-2032)
Figure 63. World Ertapenem Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Ertapenem Industry Chain
Figure 65. Ertapenem Procurement Model
Figure 66. Ertapenem Sales Model
Figure 67. Ertapenem Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
